5.670USD0.00%Mkt Cap: 69.64M $P/E: —1d ago
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astig…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap69.64M $
Enterprise Value71.49M $
Revenue (TTM)57.70M $
Gross Profit27.12M $
Net Income (TTM)-34.28M $
Revenue/Share4.787 USD
Last Price5.670 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees150
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.99
PEG—
EV/EBITDA-3.47
EV/Revenue1.24
P/S1.21
P/B6.36
EPS (TTM)-0.55
EPS (Forward)-0.71
52W Range
5.0607% of range13.43
52W High13.43 USD
52W Low5.060 USD
Profitability
Gross Margin46.41%
Oper. Margin-15.89%
EBITDA Margin-35.68%
Profit Margin-58.66%
ROE131.75%
ROA-47.99%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.83M $
CapEx (TTM)83.00K $
FCF Margin-39.28%
FCF Yield-32.55%
Net Debt-10.92M $
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity-0.11
Current Ratio2.38
Quick Ratio1.05
Book Value/Sh0.8920 USD
Cash/Share1.115 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.500 USD
Upside (mean)+49.9%
Target Range7.000 USD – 10.00 USD
$7.000+49.9% to mean$10.00
# Analysts2
Ownership
Shares Out.12.28M
Float8.66M
Insiders21.53%
Institutions52.01%
Short Interest
Short Ratio4.5d
Short % Float5.70%
Short % Out.4.12%
Shares Short505.44K
Short (prev mo.)871.80K
Technical
SMA 505.809 (-2.4%)
SMA 2009.220 (-38.5%)
Beta0.87
S&P 52W Chg20.25%
Avg Vol (30d)82.30K
Avg Vol (10d)44.36K
Technical Indicators
RSI (14)45.0
MACD-0.0126
MACD Signal0.0242
MACD Hist.-0.0369
BB Upper6.389 USD
BB Middle5.912 USD
BB Lower5.435 USD
BB Width16.14%
ATR (14)0.2843 USD
Vol Ratio (20d)0.17x